Is this you? Create Your Porfile
Avatar

Fabrice Vergne

Pfizer

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Fabrice Vergne is active.

Explore More

Publication

Featured researches published by Fabrice Vergne.

Archive | 2005

3- or 4-monosubstituted phenol and thiophenol derivatives useful as H3 ligands

Patrick Bernardelli; Andrew Michael Cronin; Alexis Denis; Stephen Martin Denton; Henry Jacobelli; Mark Ian Kemp; Edwige Lorthiois; Fiona Rousseau; Delphine Serradeil-Civit; Fabrice Vergne

Bioorganic & Medicinal Chemistry Letters | 2004

Discovery of thiadiazoles as a novel structural class of potent and selective PDE7 inhibitors. Part 1: Design, synthesis and structure–activity relationship studies

Fabrice Vergne; Patrick Bernardelli; Edwige Lorthiois; Nga Pham; Emmanuelle Proust; Chrystelle Oliveira; Abdel-Kader Mafroud; Frederique Royer; Roger Wrigglesworth; Jennifer K. Schellhaas; Mark Robert Barvian; François Moreau; Moulay Idrissi; Anita Tertre; Bernadette Bertin; Magali Coupe; Patrick Berna; Patricia Soulard

Archive | 2002

Spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors

Patrick Bernardelli; Pierre Ducrot; Edwige Lorthiois; Fabrice Vergne

Archive | 2003

Spirocondensed quinazolinones and their use as phosphodiesterase inhibitors

Patrick Bernardelli; Fabrice Vergne; Chrystelle Uk Patent Dept Pfizer Limted Mendes; Pierre Ducrot

Bioorganic & Medicinal Chemistry Letters | 2004

Spiroquinazolinones as novel, potent, and selective PDE7 inhibitors. Part 1

Edwige Lorthiois; Patrick Bernardelli; Fabrice Vergne; Chrystelle Oliveira; Abdel-Kader Mafroud; Emmanuelle Proust; Lamia Heuze; François Moreau; Moulay Idrissi; Anita Tertre; Bernadette Bertin; Magali Coupe; Roger Wrigglesworth; Arnaud Descours; Patricia Soulard; Patrick Berna

Bioorganic & Medicinal Chemistry Letters | 2004

Discovery of thiadiazoles as a novel structural class of potent and selective PDE7 inhibitors. Part 2: Metabolism-directed optimization studies towards orally bioavailable derivatives

Fabrice Vergne; Patrick Bernardelli; Edwige Lorthiois; Nga Pham; Emmanuelle Proust; Chrystelle Oliveira; Abdel-Kader Mafroud; Pierre Ducrot; Roger Wrigglesworth; Françoise Berlioz-Seux; Francis Coleon; Eric Chevalier; François Moreau; Moulay Idrissi; Anita Tertre; Arnaud Descours; Patrick Berna; Mei Li

Bioorganic & Medicinal Chemistry Letters | 2004

Spiroquinazolinones as novel, potent, and selective PDE7 inhibitors. Part 2: Optimization of 5,8-disubstituted derivatives

Patrick Bernardelli; Edwige Lorthiois; Fabrice Vergne; Chrystelle Oliveira; Abdel-Kader Mafroud; Emmanuelle Proust; Nga Pham; Pierre Ducrot; François Moreau; Moulay Idrissi; Anita Tertre; Bernadette Bertin; Magali Coupe; Eric Chevalier; Arnaud Descours; Françoise Berlioz-Seux; Patrick Berna; Mei Li

Archive | 2001

Thiadiazoles and oxadiazoles and their use as phosphodiesterase-7 inhibitors

Fabrice Vergne; Pierre Ducrot; Charles Andrianjara; Patrick Bernardelli; Edwige Lorthois

Annual Reports in Medicinal Chemistry | 2005

PDE7 Inhibitors: Chemistry and Potential Therapeutic Utilites

Fabrice Vergne; Patrick Bernardelli; Eric Chevalier

Archive | 2003

(4,2-Disubstituted-thiazol-5-yl)amine compounds as PDE7 inhibitors

Fabrice Vergne; Patrick Bernardelli; Edwige Lorthiois; Pierre Ducrot

Explore More

Collaboration

Dive into the Fabrice Vergne's collaboration.

Top Co-Authors
Avatar

Patrick Bernardelli

Pfizer

View shared research outputs
Top Co-Authors
Avatar

Edwige Lorthiois

Pfizer

View shared research outputs
Top Co-Authors
Avatar

Pierre Ducrot

Pfizer

View shared research outputs
Top Co-Authors
Avatar

Alexis Denis

Pfizer

View shared research outputs
Top Co-Authors
Avatar

Andrew Michael Cronin

Pfizer

View shared research outputs
Top Co-Authors
Avatar

Charles Andrianjara

Pfizer

View shared research outputs
Top Co-Authors
Avatar

Fiona Rousseau

Pfizer

View shared research outputs
Top Co-Authors
Avatar

Henry Jacobelli

Pfizer

View shared research outputs
Top Co-Authors
Avatar

Mark Ian Kemp

Pfizer

View shared research outputs
Top Co-Authors
Avatar

Abdel-Kader Mafroud

Pfizer

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge